BlackRock Health Sciences Term Trust (BMEZ)
NYSE: BMEZ · Real-Time Price · USD
15.12
+0.10 (0.67%)
Nov 21, 2024, 1:39 PM EST - Market open
Company Description
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
BlackRock Health Sciences Term Trust
Country | United States |
Industry | Asset Management |
Sector | Financials |
CEO | Jeffrey Gene Lee |
Contact Details
Address: 50 Hudson Yards New York, New York 10001 United States | |
Phone | 212 810 5300 |
Stock Details
Ticker Symbol | BMEZ |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001785971 |
CUSIP Number | 09260E105 |
ISIN Number | US09260E1055 |
Key Executives
Name | Position |
---|---|
Jeffrey Gene Lee | Portfolio Manager |
Dr. Xiang Liu Ph.D. | Portfolio Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 20, 2024 | SC TO-I/A | Filing |
Nov 19, 2024 | SC TO-I/A | Filing |
Oct 16, 2024 | SC TO-I | Filing |
Oct 11, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Oct 1, 2024 | SC TO-C | Filing |
Sep 5, 2024 | N-CSRS | Filing |
Aug 27, 2024 | N-PX | Annual Report of proxy voting record of management investment companies |
Aug 26, 2024 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
Aug 21, 2024 | SC TO-I/A | Filing |
Aug 20, 2024 | SC TO-I/A | Filing |